177Lu-DOTA-PTR-58
/ Starget Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 17, 2024
Nusano and Starget Pharma Announce Supply Agreement to Accelerate Smart Targeted Radioligand Development
(GlobeNewswire)
- "Nusano...and Starget Pharma...today announced a supply agreement to advance the development of Starget’s Smart Targeted Radioligands (STRs). The supply agreement is expected to support Starget’s STR isotope needs from discovery through commercialization and will include both common radioisotopes as well as rare alpha particle-emitters such as Astatine-211, Lead-212, and Actinium-225...'We are focused now on advancing our clinical pipeline, beginning with the planned initiation of a Phase 1b clinical trial in early 2025.'"
Commercial • New P1 trial • Oncology
1 to 1
Of
1
Go to page
1